Abstract
Chromohalobacter salexigens is one of nine currently known species of the genus Chromohalobacter in the family Halomonadaceae. It is the most halotolerant of the so-called ‘moderately halophilic bacteria’ currently known and, due to its strong euryhaline phenotype, it is an established model organism for prokaryotic osmoadaptation. C. salexigens strain 1H11T and Halomonas elongata are the first and the second members of the family Halomonadaceae with a completely sequenced genome. The 3,696,649 bp long chromosome with a total of 3,319 protein-coding and 93 RNA genes was sequenced as part of the DOE Joint Genome Institute Program DOEM 2004.
Highlights
Strain 1H11T (= DSM 3043 = ATCC BAA-138 = CECT 5384) is the type strain of the species Chromohalobacter salexigens [1], which is one of currently nine species in the genus Chromohalobacter [1,2]
C. salexigens 1H11T is a halophile, which according to the classification proposed by Kushner [37], is on the borderline between "moderate" halophiles and "extreme" halophiles
Genome project history This organism was selected for sequencing on the basis of the DOE Joint Genome Institute Program DOEM 2004
Summary
Strain 1H11T (= DSM 3043 = ATCC BAA-138 = CECT 5384) is the type strain of the species Chromohalobacter salexigens [1], which is one of currently nine species in the genus Chromohalobacter [1,2]. The species epithet originated from the Latin words sal salis, salt, and exigo, to demand; saltdemanding [3]. Strain 1H11T was originally isolated in 1974 in Bonair, Netherlands Antilles, from salterns containing 18.6% salt, and was initially published as a strain belonging to the species Halomonas elongata [4]. In 2001, Arahal et al transferred the strain to the genus Chromohalobacter [2] as the type strain of the novel species C. salexigens [1] following detailed phenotypic, genotypic, and phylogenetic analyses. We present a summary classification and characteristics of C. salexigens 1H11T, together with the description of the complete genomic sequencing and annotation
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
